Back to results
US 2004/0082661 A1Published application
Urea derivatives having vanilloid receptor (vr1) antagonist activity
OwnerHarshad Kantilal Rami, Mervyn Thompson +1inventors
InventorsHarshad Kantilal Rami, Mervyn Thompson, Paul Adrian Wyman
Life of this patent
Estimating the term…
Abstract
The invention relates to novel compounds having Vanilloid Receptor (VR1) antagonist activity, processes for their preparation, to compositions containing them and to their use in the treatment of various disorders.
Claims10
A compound of formula (I) or a pharmaceutically acceptable salt thereof:
- 10
- wherein:
- P is phenyl or naphthyl;
- R1 is halogen, alkyl, CF3, hydroxy, alkyloxy, CN, OCF3, alkylthio, alkylsulfinyl, alkylsulfonyl, nitro, amino, mono- or dialkylamino or C(O)alkyl;
- p is 0, 1, 2 or 3;
- n is 2, 3, 4, 5 or 6;
- R2 is halogen, alkyl, CF3, alkoxy, CN, nitro, aryl, OCF3, C(O)alkyl, amino, mono- or dialkylamino;
- q is 0, 1, 2 or 3;
- R3 is hydrogen, alkyl or arylalkyl.
6 more elements
A compound according to any of the preceding claims in which R3 is ethyl.
A process for the preparation of a compound of formula (I) or a pharmaceutically acceptable salt thereof, which process comprises coupling a compound of formula (II):
- 11
- in which R1, P and p are as defined in formula (I) with a compound of formula (III):
- 12
- in which R2, R3, n and q are as defined in formula (I) and A and B contain the appropriate functional groups which are capable of reacting together to form the urea moiety;
- and thereafter carrying out one or more of the following optional steps:
- (1) removing any protecting group;
- (2) converting R1 into another R1 or R2 into another R2 or R3 into another R3;
- and
- (3) forming a pharmaceutically acceptable salt of a compound of formula (I).
6 more elements
Dependencies are inferred from the claim text.